» Articles » PMID: 17082820

The UBL Domain of PLIC-1 Regulates Aggresome Formation

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2006 Nov 4
PMID 17082820
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Defects in protein folding and the proteasomal pathway have been linked with many neurodegenerative diseases. PLIC-1 (protein linking IAP to the cytoskeleton) is a ubiquitin-like protein that binds to the ubiquitin-interacting motif (UIM) of the proteasomal subunit S5a. Here, we show that PLIC-1 also binds to the UIM proteins ataxin 3--a deubiquitinating enzyme--HSJ1a--a co-chaperone--and EPS15 (epidermal growth factor substrate 15)--an endocytic protein. Using a polyglutamine (polyQ) disease model, we found that both endogenous PLIC-1 and EPS15 localize to perinuclear aggresomes, and that polyQ enhances their in vivo interaction. We show that knockdown of PLIC-1 and EPS15 by RNA interference reduces aggresome formation. In addition, PLIC-1(DeltaUBL) functions as a dominant-negative mutant, blocking both polyQ transport to aggresomes and the association of EPS15 with dispersed aggregates. We also show that PLIC-1 is upregulated by arsenite-induced protein misfolding. These results indicate a role for PLIC-1 in the protein aggregation-stress pathway, and we propose a novel function for the ubiquitin-like (UBL) domain--by means of UBL-UIM interactions--in transport to aggresomes.

Citing Articles

Short disordered termini and proline-rich domain are major regulators of UBQLN1/2/4 phase separation.

Dao T, Rajendran A, Galagedera S, Haws W, Castaneda C Biophys J. 2023; 123(11):1449-1457.

PMID: 38041404 PMC: 11163289. DOI: 10.1016/j.bpj.2023.11.3401.


Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer's Disease.

Rahman M, Rahman M, Mamun-Or-Rashid A, Hwang H, Chung S, Kim B Biomedicines. 2022; 10(5).

PMID: 35625764 PMC: 9138936. DOI: 10.3390/biomedicines10051027.


Association of the Protein-Quality-Control Protein Ubiquilin-1 With Alzheimer's Disease Both and .

Zhang C, Inamdar S, Swaminathan S, Marenda D, Saunders A Front Neurosci. 2022; 16:821059.

PMID: 35401099 PMC: 8992708. DOI: 10.3389/fnins.2022.821059.


Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.

Feng X, Cao A, Qin T, Zhang Q, Fan S, Wang B Oncol Rep. 2021; 46(5).

PMID: 34528694 PMC: 8453688. DOI: 10.3892/or.2021.8187.


Previously uncharacterized interactions between the folded and intrinsically disordered domains impart asymmetric effects on UBQLN2 phase separation.

Zheng T, Galagedera S, Castaneda C Protein Sci. 2021; 30(7):1467-1481.

PMID: 34029402 PMC: 8197428. DOI: 10.1002/pro.4128.


References
1.
Burnett B, Pittman R . The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc Natl Acad Sci U S A. 2005; 102(12):4330-5. PMC: 555481. DOI: 10.1073/pnas.0407252102. View

2.
Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K . Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med. 2005; 352(9):884-94. DOI: 10.1056/NEJMoa042765. View

3.
Toulouse A, Au-Yeung F, Gaspar C, Roussel J, Dion P, Rouleau G . Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum Mol Genet. 2005; 14(18):2649-60. DOI: 10.1093/hmg/ddi299. View

4.
Regan-Klapisz E, Sorokina I, Voortman J, de Keizer P, Roovers R, Verheesen P . Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction. J Cell Sci. 2005; 118(Pt 19):4437-50. DOI: 10.1242/jcs.02571. View

5.
Massey L, Mah A, Monteiro M . Ubiquilin regulates presenilin endoproteolysis and modulates gamma-secretase components, Pen-2 and nicastrin. Biochem J. 2005; 391(Pt 3):513-25. PMC: 1276952. DOI: 10.1042/BJ20050491. View